MDNews - Eastern Pennsylvania/Northwest New Jersey

September/October 2012

Issue link: https://viewer.e-digitaledition.com/i/81733

Contents of this Issue

Navigation

Page 5 of 23

COVER FEATURE St. Luke's Heart & Vascular Center THE HEART IS THE BODY'S ENGINE, BEATING OUT THE RHYTHM AND PUMPING THE BLOOD THAT CONNECTS EVERY SYSTEM AND ORGAN. AS ST. LUKE'S UNIVERSITY HEALTH NETWORK CONTINUES ITS LEAP FROM COMMUNITY HOSPITAL TO ADVANCED HUB OF CLINICAL SERVICES, THE HEART & VASCULAR CENTER IS DRUMMING OUT THE PACE FOR THE LEHIGH VALLEY REGION'S NEW HEALTH CARE STANDARD. S T. LUKE'S HEART & VASCULAR CENTER — made up of the Atrial Fibrillation Center and the Heart Valve Center, among other subspecialty programs, and with a program focusing specifically on women in the works — provides comprehensive diagnostic, medical and surgical manage- ment of the total breadth of cardiac conditions and disorders, as well as acute cardiac emergencies. A team of providers, including cardiac surgeons, electrophysi- ologists, interventional cardiologists and noninvasive cardiologists, collaborates within their own specialties and across medical fields to ensure the care of each patient is not only state of the art, but also appropriately tailored to each individual's case. Exhibiting the high quality of care it provides, St. Luke's University Health Network earned the Thomson Reuters designation as one of the nation's 50 Top Cardiovascular Hospitals for 2012. 6 | Eastern Pennsylvania/Northwest New Jersey MD NEWS ■ MDNEWS.COM Drums Out Pace for Region's New Health Care Standard Innovative Technology In its pursuit of the most cutting-edge technology for cardiac concerns, St. Luke's Heart Valve Center recently focused on aortic stenosis. The progres- sive disease affects roughly 1.5 million U.S. adults, according to the American Heart Association. Approximately 25% of those patients are between the ages of 65 and 74, which often eliminates them as candidates for surgical correction. To ensure this patient population was not relegated to suffer from symptoms that can significantly diminish quality of life, St. Luke's Heart Valve Center sought out a minimally invasive surgical inter- vention that has been used in Europe for the past decade and gained approval from the U.S. Food and Drug Administration (FDA) in November 2011. The Edwards SAPEIN Transcatheter Heart Valve — which consists of a bovine-tissue valve mounted on a stainless steel mesh frame

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Eastern Pennsylvania/Northwest New Jersey - September/October 2012